There shall be no administrative or judicial review of any of the following:
section 1320f(c)(6) of this title The determination of a unit, with respect to a drug or biological product, pursuant to .
section 1320f–1(b) of this titlesection 1320f–1(d) of this title11 So in original. The word “and” probably should not appear. section 1320f–1(e) of this title22 So in original. Probably should be preceded by “, and”. section 1320f–1(f) of this title33 So in original. The selection of drugs under , the determination of negotiation-eligible drugs under , and the determination of qualifying single source drugs under the application of ,.
section 1320f–3 of this title The determination of a maximum fair price under subsection (b) or (f) of .
section 1320f–3(f)(2) of this titlesection 1320f–3(f)(3) of this title The determination of renegotiation-eligible drugs under and the selection of renegotiation-eligible drugs under .
Aug. 14, 1935, ch. 531Pub. L. 117–169, title I136 Stat. 1851(, title XI, § 1198, as added and amended , §§ 11001(a), 11002(a)(5), , , 1861.)
Editorial Notes
Amendments
Pub. L. 117–169, § 11002(a)(5)section 1320f–1(f) of this titlesection 1320f–1(e) of this title2022—Par. (2). , which directed the amendment of subsec. (b)(2) of this section by inserting “the application of ,” after “”, was executed by making the insertion in par. (2) to reflect the probable intent of Congress.